BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 31336983)

  • 1. Are Integrins Still Practicable Targets for Anti-Cancer Therapy?
    Alday-Parejo B; Stupp R; Rüegg C
    Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31336983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-angiogenic cancer therapy based on integrin alphavbeta3 antagonism.
    Cai W; Chen X
    Anticancer Agents Med Chem; 2006 Sep; 6(5):407-28. PubMed ID: 17017851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular integrins in tumor angiogenesis: mediators and therapeutic targets.
    Alghisi GC; Rüegg C
    Endothelium; 2006; 13(2):113-35. PubMed ID: 16728329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial cell integrins and COX-2: mediators and therapeutic targets of tumor angiogenesis.
    Rüegg C; Dormond O; Mariotti A
    Biochim Biophys Acta; 2004 Mar; 1654(1):51-67. PubMed ID: 14984767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs targeting integrins for cancer therapy.
    Binder M; Trepel M
    Expert Opin Drug Discov; 2009 Mar; 4(3):229-41. PubMed ID: 23489123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin-Targeted Peptide- and Peptidomimetic-Drug Conjugates for the Treatment of Tumors.
    Arosio D; Manzoni L; Corno C; Perego P
    Recent Pat Anticancer Drug Discov; 2017; 12(2):148-168. PubMed ID: 28164756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models.
    Li Y; Drabsch Y; Pujuguet P; Ren J; van Laar T; Zhang L; van Dam H; Clément-Lacroix P; Ten Dijke P
    Breast Cancer Res; 2015 Feb; 17(1):28. PubMed ID: 25849225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiolabeled Cyclic RGD Peptide Bioconjugates as Radiotracers Targeting Multiple Integrins.
    Liu S
    Bioconjug Chem; 2015 Aug; 26(8):1413-38. PubMed ID: 26193072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrins as therapeutic targets in the organ-specific metastasis of human malignant melanoma.
    Huang R; Rofstad EK
    J Exp Clin Cancer Res; 2018 Apr; 37(1):92. PubMed ID: 29703238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional overlap and cooperativity among alphav and beta1 integrin subfamilies during skin angiogenesis.
    Perruzzi CA; de Fougerolles AR; Koteliansky VE; Whelan MC; Westlin WF; Senger DR
    J Invest Dermatol; 2003 Jun; 120(6):1100-9. PubMed ID: 12787141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond adhesion: emerging roles for integrins in control of the tumor microenvironment.
    Longmate W; DiPersio CM
    F1000Res; 2017; 6():1612. PubMed ID: 29026524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Role of RGD-Recognizing Integrins in Cancer.
    Nieberler M; Reuning U; Reichart F; Notni J; Wester HJ; Schwaiger M; Weinmüller M; Räder A; Steiger K; Kessler H
    Cancers (Basel); 2017 Sep; 9(9):. PubMed ID: 28869579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrins Within the Tumor Microenvironment: Biological Functions, Importance for Molecular Targeting, and Cancer Therapeutics Innovation.
    Dzobo K
    OMICS; 2021 Jul; 25(7):417-430. PubMed ID: 34191612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Integrins for Cancer Therapy - Disappointments and Opportunities.
    Bergonzini C; Kroese K; Zweemer AJM; Danen EHJ
    Front Cell Dev Biol; 2022; 10():863850. PubMed ID: 35356286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of tumor angiogenesis through the inhibition of integrin function and signaling in endothelial cells: which side to target?
    Rüegg C; Dormond O; Foletti A
    Endothelium; 2002; 9(3):151-60. PubMed ID: 12380640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CNTO 95, a fully human monoclonal antibody that inhibits alphav integrins, has antitumor and antiangiogenic activity in vivo.
    Trikha M; Zhou Z; Nemeth JA; Chen Q; Sharp C; Emmell E; Giles-Komar J; Nakada MT
    Int J Cancer; 2004 Jun; 110(3):326-35. PubMed ID: 15095296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment.
    Ahmed N; Riley C; Rice G; Quinn M
    Clin Exp Metastasis; 2005; 22(5):391-402. PubMed ID: 16283482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of endothelial cell integrin function and angiogenesis by COX-2, cAMP and Protein Kinase A.
    Dormond O; Rüegg C
    Thromb Haemost; 2003 Oct; 90(4):577-85. PubMed ID: 14515176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrin-mediated cancer progression as a specific target in clinical therapy.
    Chen JR; Zhao JT; Xie ZZ
    Biomed Pharmacother; 2022 Nov; 155():113745. PubMed ID: 36182738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of alphaVbeta3 and alphaVbeta5 integrins by dexamethasone in normal human osteoblastic cells.
    Cheng SL; Lai CF; Fausto A; Chellaiah M; Feng X; McHugh KP; Teitelbaum SL; Civitelli R; Hruska KA; Ross FP; Avioli LV
    J Cell Biochem; 2000 Mar; 77(2):265-76. PubMed ID: 10723092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.